Fortress Biotech Inc Pref Series A
FBIOP
$17.56-1.57%
End of day · as of Oct 12, 2026, 7:00 PM ET
Mkt cap
$44.28M
EV/Sales
0.27
P/E ratio
N/A
FY2025 Revenue
$63.26M
EPS (H1 2026)
$43.58
Gross Margin (FY2025)
66.92%
Profit Margin (FY2025)
10.77%
Beta
1.77
Div yield
N/A
Sector
Healthcare
Fortress Biotech Inc Pref Series A (FBIOP) is a biotechnology company listed on US.
Latest reported FBIOP revenue for 2025-12-31 was $63.3M. Net income was $6.8M. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. FBIOP currently screens at market cap $44.3M.
Use this FBIOP research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full FBIOP income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Fortress Biotech Inc Pref Series A (FBIOP) is a biotechnology company in the Healthcare sector.
Latest cached Fortress Biotech Inc Pref Series A (FBIOP) revenue for Dec 31, 2025 was $63.3M. Net income was $6.8M. Statements: https://lician.com/financials/fbiop
Fortress Biotech Inc Pref Series A (FBIOP) market capitalization is $44.3M on the latest cached snapshot.
Fortress Biotech Inc Pref Series A (FBIOP) cached previous close $17.84; day range $17.56 – $17.65; volume 4,929. Session quote: https://lician.com/quote/fbiop
The latest cached FBIOP filing is 8-K · Oct 1, 2026. Filings: https://lician.com/sec/fbiop